Immunohistochemical subgrouping of upper tract urothelial carcinomas by analyzing CK5 and CK20 expression can be performed in a routine setting and can identify tumors with a significantly worse cancer-specific survival prognosis. This evidence concerns the gene KRT5 and renal pelvis/ureter urothelial carcinoma.